FOXC2/ADAM12-dependent radiosensitivity of head and neck squamous cell carcinoma cells.

Zhibin Jing, Sitong Guo, Yao Li, Zheng Liang

Head & neck 2022 Jan

filter terms:

Radiotherapy greatly benefits patients with tumors, but not all patients show favorable treatment response. This study investigated the impact of forkhead box protein C2 (FOXC2)-mediated a disintegrin and metalloprotease 12 (ADAM12) on the radiosensitivity of head and neck squamous cell carcinoma (HNSCC). After transfection and ionizing radiation, the biological activities of HNSCC cells were assessed. The relationship between ADAM12 and FOXC2 was verified. A xenograft model was used to evaluate the effect of FOXC2 knockdown on HNSCC growth in the context of radiation therapy. FOXC2 and ADAM12 were upregulated in irradiated CAL-27 and HN4 cells. Knockdown of FOXC2 suppressed the malignant behaviors of CAL-27 and HN4 cells and inhibited the growth of transplanted tumors in nude mice. FOXC2 could bind ADAM12 promoter. Overexpression of ADAM12 reversed the promotion of FOXC2 silencing on the radiosensitivity of HNSCC cells. FOXC2 regulates the radiosensitivity of HNSCC by targeting ADAM12. © 2021 Wiley Periodicals LLC.

Citation

Zhibin Jing, Sitong Guo, Yao Li, Zheng Liang. FOXC2/ADAM12-dependent radiosensitivity of head and neck squamous cell carcinoma cells. Head & neck. 2022 Jan;44(1):212-225